Q-Switched 755 nm Alexandrite Laser for Pigmented Lesions
The 755 nm Q-switched alexandrite laser is highly effective for treating dermal pigmented lesions in Asian patients, but should be avoided in patients with active melasma or a history of melasma due to significant risk of worsening hyperpigmentation. 1, 2
Key Clinical Distinction: Dermal vs. Epidermal Pigmentation
The 755 nm wavelength targets melanin as its chromophore and penetrates to dermal depths, making treatment selection critically dependent on pigment location:
Appropriate Indications (Dermal Pigmentation)
- Nevus of Ota: Excellent efficacy with 75-95% clearance after 3-4 sessions 1, 3
- Hori's macules (acquired bilateral nevus of Ota-like macules): 88.89% of patients achieve moderate to marked improvement in 1-4 sessions 4
- Café-au-lait macules: Fair to good clearance after 1-7 sessions 3
- Dermal melanocytosis and Becker's nevus: Comparable efficacy to Q-switched ruby and Nd:YAG lasers 1
Contraindicated or High-Risk Conditions (Epidermal/Mixed Pigmentation)
- Active melasma: High risk of post-inflammatory hyperpigmentation (PIH) and treatment failure 2
- History of melasma: Even if currently controlled, the inflammatory response from laser treatment can trigger recurrence
- Post-inflammatory hyperpigmentation: While some case reports show improvement, this remains controversial and carries significant risk of worsening 2
Treatment Protocol for Appropriate Candidates
Technical Parameters
- Fluence: 2.73-3.98 J/cm² for dermal pigmentation 4
- Spot size: 2.4-2.9 mm 4
- Pulse duration: 650 picoseconds (newer technology) or 5-10 nanoseconds (traditional Q-switched) 4, 5
- Treatment interval: Minimum 4 weeks between sessions to allow phagocytosis and clearance of fragmented pigment 6, 7
Expected Treatment Course
- Nevus of Ota: Typically requires 3-4 sessions for excellent clearance, with delayed improvement noted only after 3 months 1, 3
- Most dermal lesions: 1-7 sessions depending on lesion type and depth 3
- Immediate post-treatment appearance: White frosting due to water vaporization, resolving within 24 hours 7, 4
Safety Profile and Risk Mitigation
Common Expected Effects
- Transient swelling and erythema in all patients, resolving within 24 hours 4
- Transient purpura and mild desquamation without scarring 5
Adverse Events in Appropriate Candidates
- Hypopigmentation: 2.78% incidence, typically transient 4
- Hyperpigmentation: 5.56% incidence in dermal lesions (significantly lower than the 25% risk reported with Q-switched lasers in epidermal conditions) 4, 3
- PIH risk in skin of color: Substantially reduced compared to traditional Q-switched lasers when treating dermal pigmentation 3
Critical Pitfalls to Avoid
- Do not treat melasma or mixed epidermal-dermal pigmentation with this wavelength, as the risk of worsening hyperpigmentation is unacceptably high 2
- Ensure proper training: Significant burns and scarring can occur with improper technique 6, 7
- Avoid treatment over photodamaged skin where the distinction between dermal and epidermal pigment is unclear 8
Patient Selection Algorithm
Step 1: Determine pigment depth
- Wood's lamp examination to differentiate epidermal (enhanced) vs. dermal (unchanged) pigmentation
- If epidermal or mixed → Do not use 755 nm Q-switched laser
Step 2: Assess for melasma history
- Current or past melasma → Absolute contraindication 2
- No melasma history → Proceed to Step 3
Step 3: Evaluate lesion type
- Nevus of Ota, Hori's macules, dermal melanocytosis → Excellent candidate 4, 1, 3
- Café-au-lait, Becker's nevus → Good candidate 1, 3
- Post-inflammatory hyperpigmentation → High-risk, consider alternative treatments
Step 4: Skin type considerations
- Fitzpatrick III-VI: Safe when treating appropriate dermal lesions 1
- Higher risk of PIH in darker skin types, but significantly lower than with epidermal pigment treatment 3
Cost and Expectations Counseling
- Treatment is expensive: $49-300 per square inch per session 6, 7
- Multiple sessions required: Average 3-4 for Nevus of Ota, up to 7 for other lesions 1, 3
- Delayed improvement: Clinical response may not be apparent until 3 months post-treatment 1
- Complete clearance not guaranteed: Some lesions show only fair to good improvement 3
Comparative Efficacy
The 755 nm alexandrite laser (both Q-switched nanosecond and newer picosecond versions) demonstrates comparable efficacy to Q-switched ruby (694 nm) and Nd:YAG (532/1064 nm) lasers for facial dermal pigmented lesions, with mean clearance of approximately 50% per treatment course 1. However, the picosecond 755 nm version shows faster clearance with minimal side effects compared to traditional Q-switched technology 4.